Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Petros Pharmaceuticals Inc (PTPI)

Petros Pharmaceuticals Inc (PTPI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,919
  • Shares Outstanding, K 9,827
  • Annual Sales, $ 9,560 K
  • Annual Income, $ -20,590 K
  • 60-Month Beta 1.86
  • Price/Sales 1.66
  • Price/Cash Flow N/A
  • Price/Book 0.81
Trade PTPI with:

Options Overview Details

View History
  • Implied Volatility 0.00%
  • Historical Volatility 67.95%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5600 +3.85%
on 10/13/21
2.0900 -22.49%
on 09/24/21
-0.2500 (-13.37%)
since 09/17/21
3-Month
1.5600 +3.85%
on 10/13/21
3.4417 -52.93%
on 07/27/21
-1.3800 (-46.00%)
since 07/19/21

Most Recent Stories

More News
Petros Pharmaceuticals Announces Closing of $5.7 Million Registered Direct Offering

/PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced the closing of its previously...

PTPI : 1.6200 (+0.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Petros Pharmaceuticals Inc. is a men's health company. It engages in identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use...

See More

Key Turning Points

3rd Resistance Point 1.7467
2nd Resistance Point 1.7133
1st Resistance Point 1.6667
Last Price 1.6200
1st Support Level 1.5867
2nd Support Level 1.5533
3rd Support Level 1.5067

See More

52-Week High 5.9599
Fibonacci 61.8% 4.2791
Fibonacci 50% 3.7599
Fibonacci 38.2% 3.2408
Last Price 1.6200
52-Week Low 1.5600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar